Punarnavadi Mandura: Classical Iron Formula for Liver and Anaemia

Punarnavadi Mandura: Clinical Protocol for Iron-Deficiency Anemia with Hepatic Involvement

Punarnavadi Mandura, also written Punarnava Mandura, is a classical Ayurvedic herbo-mineral formulation for the Pandu framework when pallor, fatigue, weak appetite, heaviness, bowel irregularity, edema tendency, or spleen-liver involvement accompany a confirmed iron-deficiency picture. It should not be used merely because hemoglobin is low; the protocol begins with laboratory confirmation of iron deficiency and an assessment of the cause of the deficiency, especially blood loss, malabsorption, inflammation, renal disease, liver disease, or nutritional inadequacy.

This is the formulation to consider when the patient needs iron support but also presents with poor digestive tolerance, agni weakness, grahani-like bowel instability, fluid retention, or hepatic context such as fatty change or altered liver markers. The liver is central to iron regulation through hepcidin, so a hepatic background makes monitoring more important, not optional. Punarnavadi Mandura should be used as part of a supervised plan that includes diet, investigation of the cause of anemia, and repeat blood testing.

Classical Formulation and Therapeutic Logic

The classical reference for Punarnava Mandura appears in Charaka Samhita, Chikitsa Sthana, Pandu Chikitsa, verses 93-96. The text lists the formula for Pandu and includes related indications such as pleeha, arsha, vishama jwara, shotha, grahani dosha, kushtha, and krimi. This is why the formula is best understood as more than a simple iron tablet: it combines an iron-containing bhasma with herbs that support digestion, bowel regulation, fluid balance, and channel clearance.

Mandura Bhasma: The Iron-Containing Base

Mandura Bhasma is the iron-containing foundation of the formulation. It is prepared through traditional purification and incineration processes and should be used only as a finished, quality-tested medicine from a reputable manufacturer. Properly prepared Mandura Bhasma has been characterized as an iron-oxide-based bhasma with fine agglomerated particles; this supports the need for standardization but does not replace clinical monitoring, contaminant testing, or practitioner supervision.

The safety of any bhasma-containing medicine depends on correct raw material selection, purification, incineration, manufacturing control, and batch testing. Punarnavadi Mandura should be sourced from a licensed manufacturer that follows recognized pharmacopeial standards and provides testing for heavy metals, microbial contamination, and identity of ingredients. Avoid loose powders, homemade bhasma, unlabeled products, or products without a batch number.

Adult Dosing and Administration

A practical adult regimen used in clinical Ayurvedic settings is 500 mg per dose, twice daily after lunch and dinner, with freshly prepared takra as the anupana. Tablet strengths vary by manufacturer, so the prescription should specify the total dose and be matched to the product label. Sensitive patients may require a lower starting dose, especially if they have gastritis, loose stools, constipation, inflammatory bowel disease, liver disease, kidney disease, or a history of poor tolerance to iron preparations.

Takra is the classical vehicle for this formulation. Its sour, fermented character fits the digestive aim of the protocol and is traditionally paired with Mandura preparations in Pandu. If buttermilk is not suitable, the substitute should be selected by the practitioner; warm water with a small amount of lime may be considered in some patients, while those with reflux, ulcers, active diarrhea, dairy intolerance, or high pitta symptoms may need a different vehicle.

Clinical Monitoring Schedule

Punarnavadi Mandura should be monitored like any iron-containing therapeutic protocol. The goal is not only symptomatic improvement but also safe correction of iron deficiency, evaluation of the cause, and avoidance of iron excess. Ferritin is useful for iron stores, but inflammation and liver disease can alter ferritin interpretation, so the wider clinical picture matters.

Diet and Supportive Measures

The diet should support agni, iron intake, and iron absorption without aggravating bowel sensitivity. Use well-cooked, digestible meals with adequate protein, iron-rich foods, and vitamin C-containing accompaniments such as amalaki, lemon, or other suitable fruits and vegetables. Tea and coffee should not be taken close to the dose or iron-rich meals, especially in patients with low ferritin.

When hepatic involvement is present, the plan should also reduce avoidable liver burden: avoid alcohol, review unnecessary supplements, correct excess sugar intake, and maintain a regular meal rhythm. Punarnavadi Mandura should not be presented as a stand-alone treatment for fatty liver; it is an anemia-centered formulation used when the broader Pandu pattern and confirmed iron deficiency justify it.

Contraindications, Cautions, and Interactions

Punarnavadi Mandura is contraindicated in known or suspected iron overload, hemochromatosis, high transferrin saturation with iron excess, and transfusion-related iron overload unless a specialist specifically directs otherwise. It should not be used empirically in thalassemia major, unexplained high ferritin, anemia of chronic disease without true iron deficiency, active gastrointestinal bleeding, severe anemia requiring urgent care, or anemia caused by B12, folate, renal, marrow, or inflammatory disorders without addressing the primary cause.

Pregnancy, lactation, childhood use, severe liver disease, chronic kidney disease, inflammatory bowel disease, active ulcers, and polypharmacy require individualized supervision. The formula contains strong digestive and bowel-moving herbs, including Chitraka, Trivrit, and Danti; do not self-administer it during pregnancy or in fragile patients.

Because Punarnavadi Mandura is iron-containing, it can interfere with the absorption of several medicines. Separate it from levothyroxine by at least four hours. It should also be spaced away from tetracycline or fluoroquinolone antibiotics and oral bisphosphonates such as alendronate, risedronate, or ibandronate according to the prescribing clinician’s instructions. Patients taking anticoagulants, thyroid medicine, diabetes medicine, acid suppressants, antibiotics, osteoporosis medicines, or multiple supplements should review timing with a physician or pharmacist.

When This Protocol Is Most Appropriate

The best fit is confirmed iron-deficiency anemia with low ferritin or compatible iron studies, along with an Ayurvedic picture of Pandu that includes weak appetite, poor assimilation, bowel irregularity, heaviness, edema tendency, or liver-spleen context. It is especially relevant when ordinary oral iron has caused digestive intolerance, provided the anemia is not severe enough to require urgent conventional replacement and the patient can be monitored.

The protocol is less appropriate when hemoglobin is low but ferritin is normal or high from inflammation, liver disease, chronic kidney disease, infection, malignancy, or hemoglobinopathy. In those cases, iron may not be the primary need, and giving iron-containing preparations without diagnosis can delay correct care or increase risk.

Medical Disclaimer: This article is educational and does not diagnose, treat, or replace medical care. Anemia requires laboratory diagnosis and investigation of the cause. Use Punarnavadi Mandura only under the supervision of a qualified Ayurvedic practitioner and healthcare provider, especially if pregnant, breastfeeding, elderly, anemic with severe symptoms, managing liver or kidney disease, or taking medication.

References

1. Charaka Samhita — Pandu Chikitsa
2. Cdn (cdn.ncbi.nlm.nih.gov)
3. Ayurvedic Pharmacopoeia of India
4. A clinical study of Punarnava Mandura in the management of Pandu Roga in old age (geriatric anemia) (2014), PubMed Central
5. Physicochemical characterization of an Iron based Indian traditional medicine: Mandura Bhasma (2011), PubMed Central
6. Journals (journals.plos.org)
7. NCBI
8. World Health Organization
9. British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults (2021), PubMed Central
10. Fao (fao.org)
11. A lactic acid-fermented oat gruel increases non-haem iron absorption from a phytate-rich meal in healthy women of childbearing age (2006), PubMed
12. CDC
13. NCCIH
14. FDA
15. Bnf (bnf.nice.org.uk)
16. Multivalent cations interactions with fluoroquinolones or tetracyclines: A cross-sectional study (2021), PubMed Central
17. Bnf (bnf.nice.org.uk)
18. NHS
19. Ijpsr (ijpsr.com)